An Alternative Booster Vaccine Against Meningitis and Ear Infections.

Trial Profile

An Alternative Booster Vaccine Against Meningitis and Ear Infections.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Mar 2018

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Jan 2018 Results of comparison of immunisation site pain between 10- or 13-Valent Pneumococcal Conjugate Vaccine published in the Pediatric Infectious Disease Journal.
    • 06 Nov 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 07 Aug 2015 Planned End Date changed from 1 Jun 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top